Cigna Corporation
NYSE:CIMedical - Healthcare Plans
-$4.44 today
- Market cap
- $75.20B
- Beta
- 0.30
- P/E (TTM)
- 11.7
- EPS (TTM)
- $23.95
- Dividend yield
- 2.19%
Volume 2.49M
Average 1.61M
CI Total Liabilities
Everything the company owes to creditors and other parties.
Cigna CorporationNYSE: CI
Total Liabilities · Q3 FY2026 · quarter ended Sep 2026
Total liabilities broadly unchanged from a year ago
Total liabilities stood at $113.92B at the end of Q3 FY2026, down 1.7% from a year earlier and down 0.2% from the prior quarter. Over 3 fiscal years it compounded at +5.4% a year.
Context
- Total liabilities amounted to 72.3% of total assets at the end of Q3 FY2026, down 1.1 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps falling in the next quarterly balance sheet after a -1.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 116.05B USD
- Year-over-year change
- +1.2%
- 4-year CAGR
- +1.9%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 116.05B | +1.2% |
| FY2024 | 2024-12-31 | 114.64B | +7.7% |
| FY2023 | 2023-12-31 | 106.41B | +7.5% |
| FY2022 | 2022-12-31 | 98.98B | -8.1% |
| FY2021 | 2021-12-31 | 107.71B | — |
Total Liabilities vs competitors
How CI compares with its peers on the latest reported figures
- CI's Sep 2026 total liabilities of $113.92B is the 3rd highest of the 9 companies compared; the peer median is $49.38B.
- Its year-over-year change of -1.7% is the 8th highest of 9, against a peer median of +4.0%.
- Total liabilities amounts to 72.3% of total assets for CI, versus a peer median of 70.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $207.24B | -1.1% | +9.3% | 66.3% | |
| Jun 2026 | $173.87B | -3.8% | +5.9% | 68.5% | |
| Sep 2026 | $113.92B | -1.7% | +5.4% | 72.3% | |
| Sep 2026 | $83.01B | +5.5% | +5.3% | 65.0% | |
| Jun 2026 | $60.36B | +2.5% | +3.1% | 72.7% | |
| Sep 2026 | $38.4B | +23.3% | +3.0% | 67.0% | |
| Sep 2026 | $11.5B | -0.1% | +7.1% | 73.5% | |
| Jun 2026 | $9.17B | +75.6% | +13.7% | 81.7% | |
| Mar 2026 | $1.05B | +34.1% | +31.0% | 83.6% | |
| Peer median (excluding CI) | $49.38B | +4.0% | +6.5% | 70.6% | |
Competitors are the stored peer set for CI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5.08B | 5.92B | 7.82B | 7.55B | 7.68B |
| Short-term Investments | 920M | 905M | 925M | 665M | 0 |
| Net Receivables | 14.62B | 16.97B | 17.45B | 24.07B | 28.77B |
| Inventory | 3.72B | 4.78B | 5.65B | 6.69B | 7.34B |
| Other Current Assets | 11.8B | 1.55B | 5.51B | 9.9B | 4.03B |
| Total Current Assets | 36.13B | 30.12B | 37.35B | 48.87B | 47.81B |
| Property, Plant & Equipment (Net) | 1.66B | 1.3B | 877M | 828M | 3.65B |
| Goodwill | 45.81B | 45.81B | 44.26B | 44.37B | 44.92B |
| Intangible Assets | 36.91B | 35.34B | 33.68B | 32.24B | 28.56B |
| Long-term Investments | 18.4B | 16.24B | 17.99B | 15.13B | 18.47B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 15.97B | 15.08B | 18.61B | 14.44B | 14.5B |
| Total Non-current Assets | 118.76B | 113.76B | 115.41B | 107.01B | 110.11B |
| Total Assets | 154.89B | 143.89B | 152.76B | 155.88B | 157.92B |
| Account Payables | 21.96B | 24.85B | 28.37B | 37.76B | 10.66B |
| Short-term Debt | 2.52B | 2.96B | 2.73B | 2.99B | 592M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.74B | 5.41B | 9.73B | 10.7B | 45.09B |
| Total Current Liabilities | 43.57B | 41.23B | 48.72B | 57.98B | 56.34B |
| Long-term Debt | 31.1B | 28.03B | 28.09B | 28.9B | 30.87B |
| Deferred Tax Liabilities | 0 | 0 | 7.17B | 6.98B | 7.15B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 32.57B | 29.46B | 22.37B | 20.75B | 21.69B |
| Total Non-current Liabilities | 64.13B | 57.91B | 57.69B | 56.66B | 59.7B |
| Total Liabilities | 107.71B | 98.98B | 106.41B | 114.64B | 116.05B |
| Common Stock | 4M | 4M | 4M | 4M | 4M |
| Retained Earnings | 32.59B | 37.87B | 41.65B | 43.52B | 47.87B |
| Accumulated OCI | (884M) | (1.4B) | (1.86B) | (2.34B) | (2.81B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 72M | 79M | 128M | 210M | 161M |
| Total Equity | 47.18B | 44.95B | 46.35B | 41.24B | 41.87B |
| Total Debt | 34.27B | 31.55B | 30.93B | 31.97B | 31.46B |
| Net Debt | 29.18B | 25.63B | 23.11B | 24.42B | 23.79B |
Cigna Corporation
NYSE:CI
Intrinsic Alpha fair value
Locked
Current Price
$285.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.